TrialsgrambetaRCTs are beautiful

SPRINT

2015

Systolic Blood Pressure Intervention Trial

In 9,361 high-risk non-diabetic hypertensive adults, intensive BP control to SBP < 120 mm Hg reduced CV events and all-cause mortality compared with standard control to SBP < 140 mm Hg.

Result

Efficacy: MI, ACS, stroke, HF or CV deathHR 0.75

Below 1 favours intensive BP control to SBP < 120 mm Hg, above 1 favours standard control to SBP < 140 mm Hg.

Event rates Intensive BP control to SBP < 120 mm Hg 1.65% vs standard control to SBP < 140 mm Hg 2.19% per year

Also reported: Mortality HR 0.73. More AKI/syncope with intensive.

Original publication
Subtopic
BP target
Design
Open-label RCT, terminated early at median 3.3 yr
Relevance
Practice-defining: a trial the guidelines cite as evidence.
Source
SPRINT Research Group. N Engl J Med. 2015;373(22):2103-2116.doi 10.1056/NEJMoa1511939

Discussion & critique

Automated office BP: readings ~ 5-10 mm Hg lower than typical clinic BP, so targets don't translate 1:1. Excluded diabetes and stroke history.

Discussed in podcasts